NCT00287066View on ClinicalTrials.gov

A Clinical Trial Assessing the Impact of Inhaled Insulin on Glucose Disposition

PHASE3TerminatedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

March 31, 2007

Conditions
Diabetes Mellitus
Interventions
DRUG

Inhaled Human Insulin

DRUG

Regular Human Insulin

Trial Locations (1)

Unknown

Pfizer Investigational Site, Pittsburgh

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY